CrystalGenomics, Inc. (083790.KQ)
KRW 2545.0
(0.99%)
KRW 2545.0
(0.99%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.55 Billion USD | -72.61% |
| 2022 | 5.67 Billion USD | -33.81% |
| 2021 | 8.57 Billion USD | -14.31% |
| 2020 | 10 Billion USD | 131.76% |
| 2019 | 4.31 Billion USD | 9.52% |
| 2018 | 3.94 Billion USD | 1.59% |
| 2017 | 3.88 Billion USD | 6.89% |
| 2016 | 3.63 Billion USD | 6.15% |
| 2015 | 3.42 Billion USD | 8.97% |
| 2014 | 3.14 Billion USD | 9.75% |
| 2013 | 2.86 Billion USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1.65 Billion KRW | 6.51% |
| 2024 Q2 | 1.53 Billion KRW | 27.89% |
| 2023 FY | 1.55 Billion USD | -72.61% |
| 2023 Q1 | 8.65 Billion USD | 52.37% |
| 2023 Q3 | 6.35 Billion USD | -43.0% |
| 2023 Q2 | 11.15 Billion KRW | 28.97% |
| 2023 Q4 | 1.55 Billion USD | -75.55% |
| 2022 FY | 5.67 Billion USD | -33.81% |
| 2022 Q3 | 5.63 Billion USD | 0.0% |
| 2022 Q1 | 5.31 Billion USD | 5.6% |
| 2022 Q4 | 5.67 Billion USD | 0.7% |
| 2021 Q4 | 5.03 Billion USD | 8.44% |
| 2021 FY | 8.57 Billion USD | -14.31% |
| 2021 Q1 | 4.66 Billion USD | 0.8% |
| 2021 Q3 | 4.63 Billion USD | 0.0% |
| 2020 Q1 | 4.44 Billion USD | -0.5% |
| 2020 Q4 | 4.62 Billion USD | 3.47% |
| 2020 FY | 10 Billion USD | 131.76% |
| 2020 Q3 | 4.47 Billion USD | 0.0% |
| 2019 FY | 4.31 Billion USD | 9.52% |
| 2019 Q4 | 4.46 Billion USD | 3.33% |
| 2019 Q1 | 4.32 Billion USD | 0.47% |
| 2019 Q3 | 4.31 Billion USD | 0.0% |
| 2018 Q1 | 4 Billion USD | -1.95% |
| 2018 FY | 3.94 Billion USD | 1.59% |
| 2018 Q4 | 4.3 Billion USD | 9.17% |
| 2018 Q3 | 3.94 Billion USD | 0.0% |
| 2017 Q1 | 3.86 Billion USD | -1.05% |
| 2017 Q4 | 4.08 Billion USD | 5.24% |
| 2017 Q3 | 3.88 Billion USD | 0.0% |
| 2017 FY | 3.88 Billion USD | 6.89% |
| 2016 Q1 | 3.59 Billion USD | 0.18% |
| 2016 Q3 | 3.63 Billion USD | 0.0% |
| 2016 Q4 | 3.9 Billion USD | 7.44% |
| 2016 FY | 3.63 Billion USD | 6.15% |
| 2015 Q1 | 3.46 Billion USD | 5.73% |
| 2015 FY | 3.42 Billion USD | 8.97% |
| 2015 Q4 | 3.59 Billion USD | 4.94% |
| 2015 Q3 | 3.42 Billion USD | 0.0% |
| 2014 Q1 | 3.13 Billion USD | 6.3% |
| 2014 FY | 3.14 Billion USD | 9.75% |
| 2014 Q4 | 3.28 Billion USD | 4.46% |
| 2014 Q3 | 3.14 Billion USD | 0.0% |
| 2013 Q4 | 2.94 Billion USD | 3.02% |
| 2013 Q3 | 2.86 Billion USD | 0.0% |
| 2013 FY | 2.86 Billion USD | 0.0% |
| 2013 Q1 | 2.79 Billion USD | 1.39% |
| 2012 Q4 | 2.75 Billion USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| HLB Co., Ltd. | 11.42 Billion KRW | 86.387% |
| iNtRON Biotechnology, Inc. | 1.01 Billion KRW | -53.772% |
| BINEX Co., Ltd. | 28.26 Billion KRW | 94.499% |
| Bioneer Corporation | 41.35 Billion KRW | 96.24% |
| Anterogen.Co.,Ltd. | 1.91 Billion KRW | 18.619% |
| MEDIPOST Co., Ltd. | 14.51 Billion KRW | 89.29% |
| Helixmith Co., Ltd | 914.11 Million KRW | -70.087% |
| Chabiotech Co.,Ltd. | 34.11 Billion KRW | 95.443% |
| Medy-Tox Inc. | 59.61 Billion KRW | 97.392% |
| Peptron, Inc. | 172.18 Million KRW | -802.965% |
| Amicogen, Inc. | 46.83 Billion KRW | 96.68% |
| Genexine, Inc. | 3.8 Billion KRW | 59.159% |
| HLB Therapeutics Co.,Ltd. | 5.33 Billion KRW | 70.861% |
| LegoChem Biosciences, Inc. | 196.83 Million KRW | -689.898% |
| ALTEOGEN Inc. | 1.06 Billion KRW | -45.531% |
| PharmaResearch Co., Ltd. | 50.23 Billion KRW | 96.905% |
| SillaJen, Inc. | 1.21 Billion KRW | -28.217% |
| JETEMA, Co., Ltd. | 12.74 Billion KRW | 87.797% |
| OliX Pharmaceuticals,Inc | 468.4 Million KRW | -231.93% |
| Genomictree Inc. | 496.53 Million KRW | -213.131% |
| MedPacto, Inc. | 620.00 KRW | -250772777.419% |
| D&D Pharmatech | 3.45 Billion KRW | 54.936% |
| EASY BIO,Inc. | 25.93 Billion KRW | 94.006% |
| GI Innovation, Inc. | - KRW | -Infinity% |